Drug discount agreements pursuant to § 130a Abs. 8 SGB V within the framework of Open-House procedures
IKK classic, DresdenTED 266413-2026
value not stated26 lots
Sun 5 Mar23:59 in Berlin
493days
Public tenders in Germany
208 open tenders
CountryTenderValueClosesDays left
Conclusion of a non-exclusive medicinal product discount agreement pursuant to § 130a para. 8 SGB V via an open-house model for the active substance Hydrocortisone (WHO ATC Code: H02AB09).
AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 32869-2026
value not stated1 lot
Fri 31 Mar23:58 in Berlin
519days
Conclusion of a non-exclusive pharmaceutical discount agreement pursuant to § 130a para. 8 of the German Social Code Book V (SGB V) via an open-house model for the active ingredient Fondaparinux (WHO ATC Code: B01AX05)
AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 56982-2026
value not stated1 lot
Fri 31 Mar23:58 in Berlin
519days
Conclusion of non-exclusive drug discount agreements under § 130a paragraph 8 of the German Social Security Code (SGB V) via an Open-House model for the active substance Urapidil (WHO ATC code: C02CA06)
AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 56028-2026
value not stated1 lot
Fri 31 Mar23:58 in Berlin
519days
Conclusion of non-exclusive drug discount agreement pursuant to § 130a, paragraph 8 of the German Social Security Code (SGB V) via an Open-House model for the active substance Vilanterol/Fluticasone (WHO ATC code: R03AK10)
AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 32969-2026
value not stated1 lot
Fri 31 Mar23:58 in Berlin
519days
Conclusion of non-exclusive drug discount agreement pursuant to § 130a, paragraph 8 of the German Social Security Code (SGB V) via an Open-House model for the active substance Palonosetron (WHO ATC code: A04AA05)
AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 60807-2026
value not stated1 lot
Fri 31 Mar23:58 in Berlin
519days
Conclusion of non-exclusive agreements for drugs with the active substance Melatonin (ATC-code: N05CH01) via an Open-House model
AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 86940-2026
value not stated1 lot
Fri 31 Mar23:58 in Berlin
519days
Conclusion of non-exclusive drug discount agreements under § 130a Abs. 8 SGB V via an Open-House model for the active substance Fusidic Acid (WHO ATC-code: D06AX01)
AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 63792-2026
value not stated1 lot
Fri 31 Mar23:58 in Berlin
519days
Conclusion of a non-exclusive pharmaceutical discount agreement pursuant to § 130a para. 8 of the German Social Code Book V (SGB V) via an open-house model for the active substance Pegfilgrastim (WHO ATC Code: L03AA13)
AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 122544-2026
value not stated1 lot
Fri 31 Mar23:58 in Berlin
519days
Conclusion of non-exclusive agreements for drugs with the active substance Fremanezumab (ATC-code: N02CD03) via an Open-House model
AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 88189-2026
value not stated1 lot
Fri 31 Mar23:58 in Berlin
519days
Conclusion of non-exclusive pharmaceutical discount agreements pursuant to § 130a para. 8 of the German Social Code Book V (SGB V) via an open-house model for the active substance Filgrastim (WHO ATC Code: L03AA02)
AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 135009-2026
value not stated1 lot
Sun 30 Apr23:58 in Berlin
549days
Conclusion of non-exclusive pharmaceutical discount agreements pursuant to § 130a para. 8 of the German Social Code Book V (SGB V) via an open-house model for the active substance Interferon beta-1a for subcutaneous injection (WHO ATC Code: L03AB07)
AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 155288-2026
value not stated1 lot
Sun 30 Apr23:58 in Berlin
549days
Conclusion of non-exclusive pharmaceutical discount agreements pursuant to § 130a para. 8 of the German Social Code Book V (SGB V) via an open-house model for the active substance Lipegfilgrastim (WHO ATC Code: L03AA14)
AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 136678-2026
value not stated1 lot
Sun 30 Apr23:58 in Berlin
549days
Conclusion of a non-exclusive discount agreement for Budesonid (WHO ATC code: A07EA06) under § 130a, paragraph 8, SGB V via an Open-House model
AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 202346-2026
value not stated1 lot
Sun 30 Apr23:58 in Berlin
549days
Pharmaceutical discount agreements pursuant to § 130a para. 8 of the German Social Code Book V (SGB V) within open-house procedures
IKK classic, DresdenTED 426545-2026
value not stated32 lots
Fri 5 May23:59 in Berlin
554days
Conclusion of non-exclusive drug discount agreement pursuant to § 130a, paragraph 8, SGB V via an Open-House model for the active substance Icatibant (WHO ATC code: B06AC02)
AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 174735-2026
value not stated1 lot
Wed 31 May23:58 in Berlin
580days
Conclusion of non-exclusive drug discount agreement pursuant to § 130a, paragraph 8, SGB V via an Open-House model for the active substance Calcipotriol/Betamethasone - Foam (official ATC code: D05AX22)
AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 213144-2026
value not stated1 lot
Wed 31 May23:58 in Berlin
580days
Conclusion of non-exclusive agreements on pharmaceuticals containing the active substance roxadustat (ATC Code: B03XA05) under an open-house model
AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 216077-2026
value not stated1 lot
Wed 31 May23:58 in Berlin
580days
Conclusion of non-exclusive drug discount agreement pursuant to § 130a, paragraph 8, SGB V via an Open-House model for the active substance Calcipotriol/Betamethasone - Cream (official ATC code: D05AX22)
AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 207477-2026
value not stated1 lot
Wed 31 May23:58 in Berlin
580days
Conclusion of non-exclusive drug discount agreement pursuant to § 130a, paragraph 8, SGB V via an Open-House model for the active substance Interferon beta-1b (WHO ATC code: L03AB08)
AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 176917-2026
value not stated1 lot
Wed 31 May23:58 in Berlin
580days
SIMAP: This is not an official publication. The data published on www.simap.ch are authoritative. SIMAP data use is subject to its terms.